FdaApplication

ANDA 220126

Back to search

Identifiers

Properties

PropertyValue
applicant_nameLNK INTERNATIONAL INC
application_typeANDA
approval_date2025-12-11

Products (1)

ProductActive ingredientStrengthDosage form
ACETAMINOPHEN AND IBUPROFENACETAMINOPHEN; IBUPROFEN250MG;125MGTABLET;ORAL

1 product